![Pharis Mohideen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pharis Mohideen
Directeur Technique/Scientifique/R&D chez
DBV TECHNOLOGIES
Fortune : 568 518 $ au 31/05/2026
Profil
Pharis Mohideen is currently Chief Medical Officer at DBV Technologies SA since 2019.
Former positions include Chief Medical Officer at Millendo Therapeutics, Inc. from 2014 to 2019; Vice President-Clinical Development at Shionogi, Inc. from 2012 to 2014; Global Head-Clinical Program at Novartis Oncology, Inc. from 2008 to 2012; Senior Director at Novartis International AG from 2006 to 2008; Principal at Bristol Myers Squibb Co.; Chief Medical Officer at Millendo Therapeutics US, Inc.; and Assistant Professor-Medicine at the University of Hawai'i at Hilo.
Education includes undergraduate, graduate, and doctorate degrees from the University of Hawai'i at Hilo and graduate studies at Vanderbilt University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
DBV TECHNOLOGIES SA 0,05 % | 15/04/2026 | 144 995 ( 0,05 % ) | 568 518 $ | 31/05/2026 |
Postes actifs de Pharis Mohideen
| Sociétés | Poste | Début |
|---|---|---|
| DBV TECHNOLOGIES | Directeur Technique/Scientifique/R&D | 22/07/2019 |
Anciens postes connus de Pharis Mohideen
| Sociétés | Poste | Fin |
|---|---|---|
| MILLENDO THERAPEUTICS | Directeur Technique/Scientifique/R&D | 12/07/2019 |
Shionogi, Inc.
 Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes antibiotics | Corporate Officer/Principal | 01/10/2014 |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Corporate Officer/Principal | 01/01/2012 |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Offers healthcare solutions | Corporate Officer/Principal | 01/01/2008 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Formation de Pharis Mohideen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
26
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Offers healthcare solutions | Health Technology |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Millendo Therapeutics US, Inc.
 Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company which develops a novel treatment for adrenal cancer | Health Technology |
Vanderbilt University
 Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Hawai'i at Hilo
 University of Hawai'i at Hilo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DBV Technologies SA
 DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy | Health Technology |
Shionogi, Inc.
Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes antibiotics | Health Technology |
Millendo Therapeutics, Inc.
 Millendo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
